NASDAQ:ORTX
Delisted

Orchard Therapeutics Stock Predictions

etoro logo Buy ORTX
*Your capital is at risk
$16.70
+0 (+0%)
At Close: Mar 15, 2024
Currently predicting for Mon, 8 Jun 2026

ORTX Prediction Chart

ORTX Predictions History

Latest community submissions for ORTX.
Predictor Target Session Target Price Result Direction Accuracy Score
AlexVel AlexVel Pro
Jan 17, 2024 $16.45 +0.07% $16.55 V 99.41% 4
Jan 16, 2024 $16.42 -0.13% $16.44 X 99.87% 5
Jan 16, 2024 $16.43 -0.08% $16.44 X 99.92% 9
AlexVel AlexVel Pro
Jan 16, 2024 $16.42 -0.14% $16.44 X 99.86% 5
AlexVel AlexVel Pro
Jan 12, 2024 $16.41 +0.08% $16.44 V 99.84% 6
AlexVel AlexVel Pro
Jan 11, 2024 $16.42 +0.02% $16.40 X 99.86% 5
AlexVel AlexVel Pro
Jan 10, 2024 $16.41 +0.06% $16.42 V 99.94% 10
AlexVel AlexVel Pro
Jan 9, 2024 $16.40 -0.03% $16.40 X 99.97% 9
AlexVel AlexVel Pro
Jan 8, 2024 $16.40 -0.01% $16.40 X 99.99% 9
AlexVel AlexVel Pro
Jan 5, 2024 $16.42 +0.07% $16.40 X 99.87% 5
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ORTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ORCHARD THERAPEUTICS PLC
Orchard Therapeutics
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's disease through a single administration. It provides Strimvelis, a gammaretroviral-based product for the...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
SAP
$172.39
7.18% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE